1889.90
-1.15%
Axis Direct
China remains a key geographic focus area for the company. Gland has received and launched one product this year. Recommendation: HOLD
ICICI Direct released a Buy report for Gland Pharma Ltd. with a price target of 2270.0 on 04 Nov, 2025.
More from Gland Pharma Ltd.
Recommended